| Leveraging multi-organ models for drug combination therapy safety | Biomedicine & pharmacotherapy |  | | 2025 | 30 | 66 |
|
| Microflow Liquid Chromatography Coupled to Multinozzle Electrospray Ionization for Improved Lipidomics Coverage of 3D Clear Cell Renal Cell Carcinoma | Analytical chemistry | | | 2025 | 44 | 30 |
|
| A cellular danse macabre: the choreography of programmed cell death | Apoptosis |  | | 2025 | 37 | 0 |
|
| Liposomal Tubacin: Strategies for the Formulation of a Highly Hydrophobic Anticancer Drug | Pharmaceutics | | | 2025 | 42 | 327 |
|
| Preclinical Photodynamic Therapy Targeting Blood Vessels withAGuIX® Theranostic Nanoparticles | Cancers | | | 2024 | 36 | 55 |
|
| Generation and maintenance of kidney and kidney cancer organoids from patient-derived material for drug development and precision oncology | Molecular therapy. Methods & clinical development | | | 2024 | 62 | 54 |
|
| Challenges in validation of combination treatment strategies for CRC using patient-derived organoids | Journal of experimental & clinical cancer research | | | 2024 | 42 | 68 |
|
| New melphalan derivatives for the treatment of retinoblastoma in combination with thermotherapy | RSC medicinal chemistry | | | 2024 | 30 | 74 |
|
| Nanoparticles Dysregulate the Human Placental Secretome with Consequences on Angiogenesis and Vascularization | Advanced science | | | 2024 | 34 | 193 |
|
| Network-informed discovery of multidrug combinations for ERα+/HER2-/PI3Kα-mutant breast cancer | Cellular and molecular life sciences | | | 2023 | 126 | 345 |
|
| Activation of endogenous glucocorticoids by HSD11B1 inhibits the antitumor immune response in renal cancer | Oncoimmunology | | | 2023 | 244 | 120 |
|
| Advanced in vitro models for renal cell carcinoma therapy design | Biochimica et biophysica acta, CR. Reviews on cancer | | | 2023 | 97 | 241 |
|
| Platform combining statistical modeling and patient-derived organoids to facilitate personalized treatment of colorectal carcinoma | Journal of experimental & clinical cancer research | | | 2023 | 182 | 96 |
|
| Extracellular vimentin mimics VEGF and is a target for anti-angiogenic immunotherapy | Nature communications | | | 2022 | 186 | 120 |
|
| Proinflammatory activity of VEGF-targeted treatment through reversal of tumor endothelial cell anergy | Angiogenesis | | | 2022 | 201 | 94 |
|
| FOLFOXIRI Resistance Induction and Characterization in Human Colorectal Cancer Cells | Cancers | | | 2022 | 256 | 189 |
|
| Characterization of Renal Cell Carcinoma Heterotypic 3D Co-Cultures with Immune Cell Subsets | Cancers | | | 2021 | 171 | 358 |
|
| Drug repurposing to identify a synergistic high-order drug combination to treat sunitinib-resistant renal cell carcinoma | Cancers | | | 2021 | 251 | 601 |
|
| A quarter century of Apoptosis | Apoptosis | | | 2021 | 222 | 1 |
|
| COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects | Angiogenesis | | | 2021 | 160 | 1 |
|
| Anti-angiogenic agents - overcoming tumour endothelial cell anergy and improving immunotherapy outcomes | Nature reviews. Clinical oncology | | | 2021 | 406 | 5 |
|
| Molecular and Functional Analysis of Sunitinib-Resistance Induction in Human Renal Cell Carcinoma Cells | International journal of molecular sciences | | | 2021 | 204 | 368 |
|
| Forcing dividing cancer cells to die; low-dose drug combinations to prevent spindle pole clustering | Apoptosis | | | 2021 | 220 | 141 |
|
| Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) | European Journal of Heart Failure | | | 2020 | 237 | 333 |
|
| Optimized low‐dose combinatorial drug treatment boosts selectivity and efficacy of colorectal carcinoma treatment | Molecular Oncology | | | 2020 | 445 | 195 |
|
| Identification of low-dose multidrug combinations for sunitinib-naive and pre-treated renal cell carcinoma | British Journal of Cancer | | | 2020 | 344 | 191 |
|
| Integrating Phenotypic Search and Phosphoproteomic Profiling of Active Kinases for Optimization of Drug Mixtures for RCC Treatment | Cancers | | | 2020 | 254 | 141 |
|
| Optimized Combination of HDACI and TKI Efficiently Inhibits Metabolic Activity in Renal Cell Carcinoma and Overcomes Sunitinib Resistance | Cancers | | | 2020 | 378 | 331 |
|
| Optimization for multidrug combinations: Challenges and perspectives in complex disorders | Pharmacological Research | | | 2020 | 391 | 4 |
|
| Drug-Drug Interactions of Irinotecan, 5-Fluorouracil, Folinic Acid and Oxaliplatin and Its Activity in Colorectal Carcinoma Treatment | Molecules | | | 2020 | 386 | 351 |
|
| Patient-Derived In Vitro Models for Drug Discovery in Colorectal Carcinoma | Cancers | | | 2020 | 348 | 356 |
|
| Programmed death, cells on the last train to glory | Apoptosis | | | 2020 | 226 | 1 |
|
| Anti-angiogenic effects of crenolanib are mediated by mitotic modulation independently of PDGFR expression | British Journal of Cancer | | | 2019 | 461 | 235 |
|
| Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer | Biochimica et Biophysica Acta. Reviews on Cancer | | | 2019 | 494 | 1,599 |
|
| Oncofoetal insulin receptor isoform A marks the tumour endothelium; an underestimated pathway during tumour angiogenesis and angiostatic treatment | British Journal of Cancer | | | 2019 | 329 | 165 |
|
| Identification of a Synergistic Multi-Drug Combination Active in Cancer Cells via the Prevention of Spindle Pole Clustering | Cancers | | | 2019 | 544 | 350 |
|
| Colorectal Cancer Growth Retardation through Induction of Apoptosis, Using an Optimized Synergistic Cocktail of Axitinib, Erlotinib, and Dasatinib | Cancers | | | 2019 | 299 | 116 |
|
| Short-term 3D culture systems of various complexity for treatment optimization of colorectal carcinoma | Scientific Reports | | | 2019 | 450 | 280 |
|
| An improved conjugate vaccine technology; induction of antibody responses to the tumor vasculature | Vaccine | | | 2018 | 324 | 265 |
|
| Targeting PDGF-mediated recruitment of pericytes blocks vascular mimicry and tumor growth | The Journal of Pathology | | | 2018 | 269 | 175 |
|
| Apoptosis on the move | Apoptosis | | | 2018 | 247 | 147 |
|
| IGF2 and IGF1R identified as novel tip cell genes in primary microvascular endothelial cell monolayers | Angiogenesis | | | 2018 | 267 | 188 |
|
| Consensus guidelines for the use and interpretation of angiogenesis assays | Angiogenesis | | | 2018 | 841 | 1,017 |
|
| Development of an Efficient Dual-Action GST-Inhibiting Anticancer Platinum(IV) Prodrug | ChemMedChem | | | 2018 | 390 | 410 |
|
| Apoptosis turns 21 | Apoptosis | | | 2017 | 223 | 118 |
|
| Epigenetic approach for angiostatic therapy: promising combinations for cancer treatment | Angiogenesis | | | 2017 | 304 | 485 |
|
| Angiogenesis inhibitors in combinatorial approaches | Angiogenesis | | | 2017 | 240 | 0 |
|
| Beyond mouse cancer models: Three-dimensional human-relevant in vitro and non-mammalian in vivo models for photodynamic therapy | Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis | | | 2017 | 213 | 0 |
|
| A genomic screen for angiosuppressor genes in the tumor endothelium identifies a multifaceted angiostatic role for bromodomain containing 7 (BRD7) | Angiogenesis | | | 2017 | 287 | 151 |
|
| Current Trends in Multidrug Optimization: An Alley of Future Successful Treatment of Complex Disorders | SLAS technology | | | 2017 | 250 | 5 |
|
| miRNAs: micro-managers of anticancer combination therapies | Angiogenesis | | | 2017 | 231 | 0 |
|
| Insulin-like growth factor axis targeting in cancer and tumour angiogenesis - the missing link | Biological Reviews | | | 2017 | 256 | 243 |
|
| Combination of ruthenium(II)-arene complex [Ru(η6-p-cymene)Cl2(pta)] (RAPTA-C) and the epidermal growth factor receptor inhibitor erlotinib results in efficient angiostatic and antitumor activity | Scientific Reports | | | 2017 | 293 | 195 |
|
